The Hidden Prices We Pay for Genetically Modified Seeds
Last week, the Supreme Court ruled that Monsanto can control how farmers use its genetically-modified soybean seeds. Here's why those little beans are a big deal to you.
roundup
What to Watch This Week: Seeds, Sex, Schools and FedEx
On Monday, the stock market will take the day off to shake the confetti out of its hair. But on Tuesday, it'll be back to business as usual on Wall Street. Here are some of the items that will shape the first trading week of 2012.
2010's Biggest Tech Surprises and Disappointments
Forecasting which technologies will succeed is always hazardous, but it proved especially difficult in 2010, a year full of surprises -- and also several disappointments. Facebook blew away even the most optimistic expectations for the year. Google Buzz? Not so much.
Pharma News Briefs: Human Genome, Merck, Novartis
Here's a roundup of some of Wednesday's major pharmaceutical news: An FDA panel gave Human Genome Sciences a boost with a thumbs-up for its lupus drug, Benlysta; Merck's experimental heart drug appears to work well without side effects; and Novartis announced its plans for long-term growth.
